首页> 外文期刊>Genetic epidemiology. >Phase uncertainty in case-control association studies.
【24h】

Phase uncertainty in case-control association studies.

机译:病例对照研究中的阶段不确定性。

获取原文
获取原文并翻译 | 示例
           

摘要

The possible evidence for association comprises three types of information: differences between cases and controls in allele frequencies, in parameters for Hardy-Weinberg disequilibrium (HWD), and in parameters for linkage disequilibrium (LD). LD between marker and disease alleles results in a difference in at least one of the three types of parameters [Won and Elston, 2008]. However, the parameters for LD require knowledge about phase, which is usually unknown, making the LD contrast test without modification infeasible in practice. Methods for handling phase uncertainty are: (1) the most probable haplotype pair for each individual can be considered as the true phase; (2) a weighted average of haplotypes can be used; (3) we can consider the composite LD, which does not require any information about phase. We compare these methods to handle phase uncertainty in terms of validity and efficiency, and the effect on them of HWD in the population, at the same time confirming results for the three types of information. When the LD between markers is high, the LD contrast test that uses a weighted average of haplotypes or the most probable haplotypes to calculate the LD is recommended, but otherwise the LD contrast test that uses the composite LD is recommended. We conclude that, even though the difference in allele frequencies is usually the most informative test except in the case of a recessive disease, the LD contrast test can be more powerful if the markers are dense enough.
机译:可能的关联证据包括三种类型的信息:等位基因频率,Hardy-Weinberg不平衡(HWD)参数和连锁不平衡(LD)参数之间病例与对照之间的差异。标记等位基因和疾病等位基因之间的LD导致三种类型参数中的至少一种存在差异[Won and Elston,2008]。然而,用于LD的参数需要关于相位的知识,这通常是未知的,这使得在实践中不进行修改的LD对比测试是不可行的。处理相位不确定性的方法是:(1)每个个体最可能的单倍型对可以视为真实相位; (2)可以使用单倍型的加权平均值; (3)我们可以考虑复合LD,它不需要任何有关相位的信息。我们比较这些方法来处理阶段不确定性的有效性和效率,以及对人群中HWD的影响,同时确认三种类型信息的结果。当标记之间的LD高时,建议使用单倍型或最可能的单倍型的加权平均值来计算LD的LD对比测试,否则建议使用复合LD的LD对比测试。我们得出结论,尽管等位基因频率的差异通常是最有用的测试,但对于隐性疾病而言,如果标记足够密集,LD对比测试可能会更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号